首页>
外国专利>
SERUM BIOMARKERS FOR PREDICTING AND EVALUATING RESPONSE TO TNF INHIBITOR THERAPY IN RHEUMATOID ARTHRITIS PATIENTS
SERUM BIOMARKERS FOR PREDICTING AND EVALUATING RESPONSE TO TNF INHIBITOR THERAPY IN RHEUMATOID ARTHRITIS PATIENTS
展开▼
机译:用于预测和评估类风湿性关节炎患者TNF抑制剂治疗的血清生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present disclosure is directed to methods and kits of use of serum biomarkers, including CXCL10, CXCL13, and/or sCD27, for predicting and evaluating therapeutic response to TNF inhibitor therapy in a patient in need thereof.
展开▼